Conversion therapy for initially unresectable gallbladder cancer after combination chemotherapy with gemcitabine and cisplatin

Tsutomu Takenami, Kei Nakagawa, Tomoyoshi Tachibana, Shinichi Yabuuchi, Hideaki Karasawa, Yu Katayose, Fuyuhiko Motoi, Takeshi Naito, Fumiyoshi Fujishima, Michiaki Unno

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Conversion therapy for initially unresectable gallbladder cancer after combination chemotherapy with gemcitabine and cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences